Primary information |
---|
ID | 1515 |
Peptide Name | SEQ ID35 |
Sequence | rlylrlllGy |
Length | 10 |
Chirality | Mix |
N-terminal Modification | Acetylation |
C-terminal Modification | Amidation |
Chemical Modification | None |
Linear/ Cyclic | Linear |
Nature | Synthetic |
Source of Origin | NA |
Target | NA |
Mechanism of Action | Inhibited T-cell proliferation, various inflammatory cytokines production. |
In vitro/In vivo | In vivo |
Cell Line | None |
Inhibition Concentartion | 2.5-10micromolar against binding to peptides to HSC90 |
In vivo Model | C57BL6/J, Balb/c and CBA/J mice |
Assay | Enzyme-linked immunosorbent assay (ELISA) |
Lethal Dose | NA |
Combination Therapy | LPS |
Pubmed ID | US 7267822 B2 |
Year of Publication | 2007 |
3-D Structure | View in Jmol or Download Structure |